NCT02724202 2026-02-06
Curcumin in Combination With 5FU for Colon Cancer
Baylor Research Institute
Phase EARLY_PHASE1 Terminated
Clinical Trials
17 trialsNCT04871412 2026-01-30
POISE
Ottawa Hospital Research Institute
Phase 3 Recruiting
NCT07248020 2025-11-25
BCMRECRAD
Chang Gung Memorial Hospital
Phase 2 Not yet recruiting
NCT02782949 2025-09-15
Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric Intestinal Metaplasia
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT05472753 2025-02-12
TERATROFO
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
Phase NA Completed
NCT01859858 2023-12-04
Effect of Curcumin on Dose Limiting Toxicity and Pharmacokinetics of Irinotecan in Patients With Solid Tumors
UNC Lineberger Comprehensive Cancer Center
Phase 1 Completed
NCT05856500 2023-05-18
A Study of Creatine Combined With Curcumin in the Intervention of Early Cachexia in Upper Gastrointestinal Tumors
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase NA Unknown
NCT02439385 2022-03-31
Avastin/FOLFIRI in Combination With Curcumin in Colorectal Cancer Patients With Unresectable Metastasis
Gachon University Gil Medical Center
Phase 2 Completed
NCT00927485 2020-12-16
Use of Curcumin for Treatment of Intestinal Adenomas in Familial Adenomatous Polyposis (FAP)
University of Puerto Rico
Phase NA Completed
NCT01490996 2020-01-31
CUFOX
University of Leicester
Phase 1/2 Completed
NCT00973869 2014-06-24
Curcumin in Preventing Colorectal Cancer in Patients Undergoing Colorectal Endoscopy or Colorectal Surgery
National Cancer Institute (NCI)
Phase 1 Unknown
NCT00027495 2012-12-21
Curcumin for the Prevention of Colon Cancer
University of Michigan Rogel Cancer Center
Phase 1 Completed
NCT00248053 2012-09-20
Use of Curcumin in the Lower Gastrointestinal Tract in Familial Adenomatous Polyposis Patients
Johns Hopkins University
Phase 2 Withdrawn
NCT00003365 2011-01-27
Sulindac and Plant Compounds in Preventing Colon Cancer
Rutgers, The State University of New Jersey
Phase NA Terminated
NCT00192842 2010-09-22
Gemcitabine With Curcumin for Pancreatic Cancer
Rambam Health Care Campus
Phase 2 Completed
NCT00486460 2007-06-14
Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Advance or Inoperable Pancreatic Cancer
Tel-Aviv Sourasky Medical Center
Phase 3 Unknown
NCT00295035 2006-02-22
Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Metastatic Colon Cancer
Tel-Aviv Sourasky Medical Center
Phase 3 Unknown